Last reviewed: 16 Sep 2021
Last updated: 08 Sep 2021

Summary

Differentials

Common

  • Minimal change disease
  • Focal segmental glomerulosclerosis (FSGS)
  • Membranous nephropathy
  • Diabetic nephropathy
  • Multiple myeloma-associated AL amyloidosis
  • IgA nephropathy

Uncommon

  • Membranoproliferative (mesangiocapillary) glomerulonephritis
  • Amyloidosis
  • Lupus nephritis
  • Fabry's disease
  • Alport's syndrome
  • Nail-patella syndrome
  • Malignant hypertension

Contributors

Authors

Ruth Pepper, PhD, FRCP

Consultant Nephrologist

UCL Honorary Senior Lecturer

Royal Free Hospital

London

UK

Disclosures

RP declares that she has no competing interests.

John Connolly, PhD, FRCP

Medical Director Royal Free Hospital

Group Director Clinical Pathways

London

UK

Disclosures

JC declares that he has no competing interests.

Acknowledgements

Dr Ruth Pepper and Dr John Connolly would like to gratefully acknowledge David J.A. Goldsmith, Dr Oliver J. Ziff, and Dr Michael S. Gersch, previous contributors to this topic. DJAG, OJZ, and MSG declare that they have no competing interests.

Peer reviewers

John Feehally, MBBS, FRCP

Professor of Renal Medicine

The John Walls Renal Unit

Leicester General Hospital

Leicester

UK

Disclosures

JF declares that he has no competing interests.

Judith H. Veis, MD, FASN

Associate Director

Nephrology

Washington Hospital Center

Washington

DC

Disclosures

JHV declares that she has no competing interests.

Catherine Clase, BA, MB, MSC, FRCPC

Associate Professor

Department of Medicine

McMaster University

Ontario

Canada

Disclosures

CC declares that she has no competing interests.

Use of this content is subject to our disclaimer